Australia: Therapeutic Goods Administration (TGA)

The national authority

The Therapeutic Goods Administration is Australia's national regulator for medicines, medical devices, and biological products such as blood, tissues, and cell therapies. It operates within the Australian Government Department of Health and Aged Care, and its decisions apply across the country rather than state by state.

The TGA's mandate covers the full product lifecycle: what may be supplied, how products are manufactured and licensed, how they are advertised, and how safety problems are handled after supply.

How products enter the market

Almost every therapeutic product supplied in Australia must appear on the Australian Register of Therapeutic Goods, the public database of approved and listed products, before it can legally be marketed. Higher-risk products - prescription medicines, most over-the-counter medicines, and most devices - are registered after evaluation of quality, safety, and efficacy data.

Lower-risk complementary medicines such as most vitamin and herbal products follow a listing route with a lighter assessment, in which sponsors certify that the product meets the rules rather than undergoing full pre-market evaluation.

Medical devices are classified by risk, from low-risk Class I products through Class IIa and IIb to the highest-risk Class III, with in-vitro diagnostics on a parallel scale. Higher classes require more extensive conformity assessment before inclusion in the register.

Approval pathways and special access

Prescription medicines reach the market through a formal registration application, with generic medicines assessed against an already-approved reference product. Australia also operates pathways to speed access for seriously ill patients, including priority review for promising new medicines and provisional registration, which allows time-limited marketing on preliminary data while full evidence is gathered.

For individual patients with serious conditions, schemes such as the Special Access Scheme and the Authorised Prescriber scheme allow supply of products that are not yet on the register at all, under medical supervision.

Using this profile

Administrators and researchers working with Australian product data should treat register inclusion, and its stated product type and class, as the primary record of regulatory status. Sponsors hold the registration; manufacturing sites are licensed separately; advertising and recall decisions sit with the authority.

For cross-country comparison: Australia participates in international harmonization initiatives and has reliance-style arrangements with comparable regulators, so Australian decisions often reference assessments from Europe and North America. The authority portal listed in this profile's internal reference record is the primary source for current rules and registry searches.